The International Waldenstrom's Macroglobulinemia Foundation Inc
Mission objectives: (a) offer support and encouragement to the waldenstrom's macroglobulinemia community and others with an interest in the disease, (b) to provide information and educational programs that address patients and caregivers' concerns and (c) to provide and support research leading to better treatments and ultimately a cure.
The International Waldenstrom's Macroglobulinemia Foundation Inc at a glance
In short: The International Waldenstrom's Macroglobulinemia Foundation Inc gave $2.1M across 6 grants in 2024 (avg $357K), mostly in Massachusetts. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $2,143,879
- +61.3% vs 2023
- Grants made (2024)
- 6
- +0.0% vs 2023
- Average grant
- $357,313
- +61.3% vs 2023
- Median grant
- $199,975
- Total assets
- $7,467,490
- -10.3% vs 2023
- Primary geography
- Massachusetts (74% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated September 2026.
How to apply to The International Waldenstrom's Macroglobulinemia Foundation Inc
Open Grants
12 open opportunities from The International Waldenstrom's Macroglobulinemia Foundation Inc
2026 Research Request for Proposals (RFP)
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$250,000 - $1,000,000 over 2-4 years
Deadline
Deadline not published
Companion Grant
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$120,000 total
Deadline
Deadline not published
Enhanced Roadmap Grant
The International Waldenstrom's Macroglobulinemia Foundation Inc
Amount
$1,500,000 total
Deadline
Deadline not published
Who The International Waldenstrom's Macroglobulinemia Foundation Inc funds
How this funder distributes its grants
Top Recipients
Top 6 recipients in 2024
The largest 2024 recipient was Dana Farber Cancer Institute ($1.3M). Together the top 6 received $2.1M.
Grant Size Distribution
29 grants across all recorded years
The most common grant size was under $50K: 10 grants of 29 (34%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
Share of 2024 grant dollars across all 6 itemized grants.
Cities
How The International Waldenstrom's Macroglobulinemia Foundation Inc gives
- Giving grew 90% from 2021 to 2024. Method
From the foundation's IRS Form 990 filings. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $933K (2022) to $2.1M (2024). In 2024 it made 6 grants totaling $2.1M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Dana Farber Cancer Institute Boston, MA | Research | $1,262,440 |
| Mayo Clinic Mineapolis, MN | Research | $421,489 |
| NYU School of Medicine Boston, MA | Research | $320,000 |
| The Ohio State University Columbus, OH | Research | $79,950 |
| University of CA San Diego La Jolla, CA | Research | $30,000 |
| Memorial Sloan-Kettering Cancer Center New York, NY | Research | $30,000 |
Ready to take the next step with The International Waldenstrom's Macroglobulinemia Foundation Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $7,467,490 | $4,463,374 | $5,497,731 | $2,143,879 | 6 | $305,481 |
| 2023 | $8,329,477 | $3,292,131 | $4,066,709 | $1,328,887 | 6 | $226,174 |
| 2022 | $9,055,891 | $4,169,452 | $2,555,918 | $933,333 | 6 | $30,904 |
| 2021 | $7,402,039 | $4,461,160 | $2,455,198 | $1,125,815 | 6 | $3,028 |
| 2020 | $5,317,932 | $4,079,734 | $2,596,374 | $1,247,166 | 5 | $7,114 |
About The International Waldenstrom's Macroglobulinemia Foundation Inc
Based on IRS filings
The International Waldenstrom's Macroglobulinemia Foundation Inc is a public charity focused on Diseases, Disorders & Medical Disciplines, based in Sarasota, FL. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $7.5M in total assets. In 2024, it awarded 6 grants totaling $2.1M. Net investment income was $305K.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
The International Waldenstrom's Macroglobulinemia Foundation Inc is led by Louie Newton Guerin, President & CEO on the 2024 filing; 2 of 19 officers listed in 2024 are compensated.
Officers on the 2024 filing
Louie Newton Guerin
President & CEO
New on the 2024 filing
40 hrs/week
$157K (2024)
Paul Kitchen
Chairman
Trustee → Chairman, 2024
On filings since 2020
30 hrs/week
No compensation reported
Annette Preston
Director of Development
New on the 2024 filing
40 hrs/week
$111K (2024)
Linda Nelson
Trustee
On filings since 2020
15 hrs/week
No compensation reported
Meg Mangin
Trustee
On filings since 2020
15 hrs/week
No compensation reported
Shirley Ganse
Trustee
On filings since 2020
15 hrs/week
No compensation reported
Stephen Ansell MD PhD
Trustee
On filings since 2020
15 hrs/week
No compensation reported
Glenn Cantor Dvm PhD
Trustee
On filings since 2023
15 hrs/week
No compensation reported
Saurabh Seroo
Trustee
On filings since 2023
15 hrs/week
No compensation reported
Carol Welsh Gray
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
Craig Prizant
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
David Schnell
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
Eileen Sullivan
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
John Zimmerman
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
Robert Perry
Trustee
New on the 2024 filing
15 hrs/week
No compensation reported
Carl Lisman
Secretary & Treasurer
Trustee → Secretary & Treasurer, 2022
On filings since 2020
15 hrs/week
No compensation reported
Carl Harrington
Vice Chair Fundraising
On filings since 2023
15 hrs/week
No compensation reported
Lisa Wise
Vice Chair Info & Support
Vice Chair Information & Support → Vice Chair Info & Support, 2024
On filings since 2023
15 hrs/week
No compensation reported
Thomas Hoffman MD
Vice Chair Research
On filings since 2023
15 hrs/week
No compensation reported
Former officers (11)
- Former: Newton Guerin (2020–2023) — President & CEO
- Former: Peter Denardis (2020–2023) — Chairman
- Former: Steven Treon MD PhD (2023) — Board Advisor
- Former: Glenn Cantor (2020–2022) — Trustee
- Former: Lisa J. Wise Med (2020–2022) — Vice President for Member
- Former: Ron Branscome (2020–2022) — Vice President for Fundrai
- Former: Thomas H. Hoffmann Md Facsaccp (2020–2022) — Vice President for Researc
- Former: David Kahn (2022) — Trustee
- Former: Julie Richardson (2022) — Trustee
- Former: Beverly Docteur (2020–2021) — Secretary & Treasurer
- Former: Michael Sesnowitz (2020) — Vice President for Fundrai
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $157K, to Louie Newton Guerin (President/CEO). 2 officers or directors reported compensation on that filing.
Frequently asked questions about The International Waldenstrom's Macroglobulinemia Foundation Inc
How much does The International Waldenstrom's Macroglobulinemia Foundation Inc give each year?
The International Waldenstrom's Macroglobulinemia Foundation Inc gave $2.1M across 6 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $1.3M across 6 grants.
What is The International Waldenstrom's Macroglobulinemia Foundation Inc's typical grant size?
The International Waldenstrom's Macroglobulinemia Foundation Inc's median grant in 2024 was $199,975, and its average grant was $357,313, across 6 grants on its 2024 IRS Form 990.
Where does The International Waldenstrom's Macroglobulinemia Foundation Inc give grants?
The International Waldenstrom's Macroglobulinemia Foundation Inc gives mostly in Massachusetts: 74% of the grant dollars itemized on its 2024 IRS Form 990 went to recipients there. The next largest state was Minnesota (20%). The most frequent recipient cities were Boston, MA (2 grants).
Does The International Waldenstrom's Macroglobulinemia Foundation Inc give general operating support?
Not in 2024: none of the 6 grants with a stated purpose on The International Waldenstrom's Macroglobulinemia Foundation Inc's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Research" (6 grants).
Who are The International Waldenstrom's Macroglobulinemia Foundation Inc's largest grantees?
The International Waldenstrom's Macroglobulinemia Foundation Inc's largest 2024 grantees include Dana Farber Cancer Institute ($1,262,440), Mayo Clinic ($421,489) and NYU School of Medicine ($320,000), according to its 2024 IRS Form 990. Together they received 93% of its itemized 2024 grant dollars.
How large is The International Waldenstrom's Macroglobulinemia Foundation Inc?
The International Waldenstrom's Macroglobulinemia Foundation Inc reported $7.5M in total assets on its 2024 IRS Form 990. Its revenue that year was $4.5M.
What is The International Waldenstrom's Macroglobulinemia Foundation Inc?
The International Waldenstrom's Macroglobulinemia Foundation Inc is a public charity focused on Diseases, Disorders & Medical Disciplines, based in Sarasota, FL. It holds $7.5M in total assets as of 2024.
What is The International Waldenstrom's Macroglobulinemia Foundation Inc's EIN?
The International Waldenstrom's Macroglobulinemia Foundation Inc's EIN (Employer Identification Number) is 54-1784426. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS October 4, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS September 29, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS August 31, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 1, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS September 3, 2025)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work The International Waldenstrom's Macroglobulinemia Foundation Inc funds
Diseases, Disorders & Medical Disciplines Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in The International Waldenstrom's Macroglobulinemia Foundation Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Cancer Society Inc
Atlanta, GA
The American Cancer Society funds cancer research, patient support, and advocacy, including grants to researchers, institutions, and related organizations. Its 2025 grants ranged from $5,648 to $9.6 million, with a median of $15,000; research funding supports institutions across the United States. It accepts applications for specific research programs through ProposalCentral, but the profile does not state whether it accepts unsolicited requests generally.
Assets
$1.7B
Grants
509
Total Given
$23.1M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
Conquer Cancer Foundation of the American Society of Clinical Oncology
Alexandria, VA
Conquer Cancer funds cancer research, professional education, and quality-care initiatives, with awards to universities, hospitals, and cancer centers in the U.S. and through international programs. Its 2024 grants ranged from $50,000 to $7.68 million, with a median of $100,000; the profile does not state whether it accepts unsolicited requests.
Assets
$120.7M
Grants
39
Total Given
$17.4M
Breakthrough T1D
New York, NY
Breakthrough T1D funds research to cure, prevent, and treat type 1 diabetes and its complications, as well as related education and support. Its 2025 grants ranged from $25,000 to $7.28 million, with a median of about $378,000, and went to organizations in multiple states; eligible Conference Award applications are accepted year-round.
Assets
$534.6M
Grants
100
Total Given
$79.3M
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
Yale University
New Haven, CT
Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.
Assets
$58.9B
Grants
364
Total Given
$168.2M
More similar funders
More Funders in Florida
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from The International Waldenstrom's Macroglobulinemia Foundation Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
The International Waldenstrom's Macroglobulinemia Foundation Inc down — hundreds of funders to go?